- Home
- MDXG
MDXG
MiMedx Group Inc
as of 12-05-2025 3:45pm EST
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | MARIETTA |
| Market Cap: | 1.0B | IPO Year: | N/A |
| Target Price: | $12.00 | AVG Volume (30 days): | 777.2K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.27 | EPS Growth: | -47.92 |
| 52 Week Low/High: | $5.79 - $10.14 | Next Earning Date: | 10-29-2025 |
| Revenue: | $393,442,000 | Revenue Growth: | 14.77% |
| Revenue Growth (this year): | 19.13% | Revenue Growth (next year): | 2.11% |
AI-Powered MDXG Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of MiMedx Group Inc (MDXG)
Chief Commercial Officer
Avg Cost/Share
$7.42
Shares
58,300
Total Value
$432,329.48
Owned After
236,982
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Maersk-Moller Kimberly | MDXG | Chief Commercial Officer | Nov 6, 2025 | Sell | $7.42 | 58,300 | $432,329.48 | 236,982 |
Compare MDXG vs Leading Stocks
See how MDXG stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "MDXG MiMedx Group Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.